Ameritas Investment Partners, Inc. - RENEO PHARMACEUTICALS INC ownership

RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 39 filers reported holding RENEO PHARMACEUTICALS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
Ameritas Investment Partners, Inc. ownership history of RENEO PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$6,084
+16.1%
7990.0%0.00%
Q2 2023$5,241
+424.1%
799
+61.7%
0.00%
Q1 2022$1,000
-75.0%
4940.0%0.00%
Q4 2021$4,0000.0%4940.0%0.00%
Q3 2021$4,000
-20.0%
4940.0%0.00%
Q2 2021$5,0004940.00%
Other shareholders
RENEO PHARMACEUTICALS INC shareholders Q3 2021
NameSharesValueWeighting ↓
Abingworth LLP 1,962,221$18,190,0005.62%
RiverVest Venture Management LLC 2,409,220$22,478,0004.39%
Novo Holdings A/S 3,430,377$32,005,0001.42%
Aisling Capital Management LP 886,075$8,267,0001.32%
NEA Management Company, LLC 4,786,921$44,662,0000.58%
Prosight Management, LP 54,934$513,0000.32%
Rock Springs Capital Management LP 1,129,024$10,534,0000.21%
Pinz Capital Management, LP 56,823$530,0000.16%
TYBOURNE CAPITAL MANAGEMENT (HK) LTD 750,000$6,998,0000.15%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 849,300$7,924,0000.14%
View complete list of RENEO PHARMACEUTICALS INC shareholders